Retrospective analysis of 55,769 HbA1c EQA results obtained from professional laboratories and medical offices participating in surveys organized by two European EQA centers over a nine‐year period
Authors:
- Pierre‐Alain MorandiPMPierre‐Alain Morandi
- André DeomADAndré Deom
- Dagmar KesselerDKDagmar Kesseler
- Richard CohenRCRichard Cohen
- 1 January 2011
- journal article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 25 (5) , 337-343
Abstract
External Quality Assessment (EQA) is an essential tool for laboratories to monitor the performances of their analyses. It also allows a comparison of methods and types of laboratories (professional laboratories vs. medical offices). We, therefore, compared 55,769 HbA1c EQA results obtained between 1999 and 2008 by laboratories participating in EQA schemes organized by two European centers, Switzerland (center 1) and France (center 2). We used simple, nonparametrical statistics suited to EQA results to calculate the yearly and global precision performances. All the results, including the outliers, were included in the calculations. The best global precision performances were obtained by professional laboratories and medical offices using DCA POCT devices, followed byprofessional laboratories with the Integra, Hitachi, Cobas Mira, and HPLC groups of devices, and finally by both types of laboratories with the NycoCard POCT devices. When considering yearly precision performances, an overall improvement over time was observed for almost all diagnostic devices of center 1, whereas the trend was less clear for center 2. The HbA1c EQA results collected and analyzed over a 9‐year period showed that the DCA POCT devices used either by professional laboratories or medical offices had better reproducibility than laboratory devices (other than POCT) and that a general improvement of yearly precision performances was observed, especially when frequent EQA schemes were organized. J. Clin. Lab. Anal. 25:337–343, 2011.Keywords
This publication has 21 references indexed in Scilit:
- Six of Eight Hemoglobin A1c Point-of-Care Instruments Do Not Meet the General Accepted Analytical Performance CriteriaClinical Chemistry, 2010
- Type 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategiesJournal of the American Pharmacists Association, 2009
- Evaluation of HbA1c on the Roche COBAS Integra 800 closed tube systemClinical Biochemistry, 2007
- External quality control results of urine dip-slide devicesDiagnostic Microbiology and Infectious Disease, 2007
- Nurse-based evaluation of point-of-care assays for glycated haemoglobinClinica Chimica Acta, 2006
- Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) StudyPediatric Diabetes, 2005
- Quality specifications in EQA schemes: from theory to practiceClinica Chimica Acta, 2004
- Évolution des résultats du dosage du PSA total (antigène spécifique de la prostate) : données obtenues dans le cadre d'un programme de contrôle de qualité interlaboratoireImmuno-analyse & Biologie Spécialisée, 2000
- Assessment of the state-of-the-art trueness and precision of serum total-calcium and glucose measurements in Finnish laboratories - the QSL-Finland studyScandinavian Journal of Clinical and Laboratory Investigation, 1998
- Blood glucose: Its measurement and clinical importanceClinica Chimica Acta, 1996